HER2 Support Group Forums - View Single Post - Pitavastatin shows pomise in overcoming chemotherapy resistance in triple-negative br

News · 01-07-2026, 08:41 AM

Triple-negative breast cancer (TNBC) is among the most aggressive types of breast cancer, lacking estrogen, progesterone, and HER2 receptors and thus relying primarily on cytotoxic chemotherapy.

More...

01-07-2026, 08:41 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 20,052	Pitavastatin shows pomise in overcoming chemotherapy resistance in triple-negative br Triple-negative breast cancer (TNBC) is among the most aggressive types of breast cancer, lacking estrogen, progesterone, and HER2 receptors and thus relying primarily on cytotoxic chemotherapy. More...